Comparative evaluation of the humoral immune interaction when BCG and conjugated meningococcal vaccines combined or co-administrated in mice

Comp Immunol Microbiol Infect Dis. 2022 May:84:101778. doi: 10.1016/j.cimid.2022.101778. Epub 2022 Feb 24.

Abstract

BCG and conjugated meningococcal vaccines (cMen) are part of the recommended immunization program for young children (<5 years) in many countries all over the world. However, there was no immunogenicity supportive data to assess the effect of BCG and cMen vaccines when combined or co-administrated. Therefore, we sought to evaluate the antibody response in mice groups when BCG and cMen vaccines were whether in combination, co-administration simultaneously or administration with a 14-day gap interval. Our results showed that cMen either combined with BCG vaccine or co-administrated had a significant negative humoral immune effect on each other. This negative impact was observed also when there were 2 weeks between their administration regardless of the vaccination order. Therefore, our results support that it is preferable to separate the two vaccination for > 14 days at least. But additional studies are needed to explore the cellular-mediate response of the immune intervention as well.

Keywords: BCG; Co-administration; Combined; Conjugated meningococcal; Vaccine.

MeSH terms

  • Animals
  • Antibodies, Bacterial
  • BCG Vaccine
  • Meningococcal Vaccines*
  • Mice
  • Vaccination / veterinary
  • Vaccines, Combined

Substances

  • Antibodies, Bacterial
  • BCG Vaccine
  • Meningococcal Vaccines
  • Vaccines, Combined